Vinflunine in Metastatic Urothelial Carcinoma of the Bladder in Progression after a Platinum-Containing Regimen.

DISCUSSION: In this real-word non-randomized clinical trial setting, the data showed that vinflunine is an efficacious and safe therapeutic option for second-line treatment of patients with metastatic urothelial carcinoma of the bladder after a platinum-containing regimen. PMID: 31461721 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31461721?dopt=Abstract

Source: Oncology - August 27, 2019 Category: Cancer & Oncology Authors: De Luca R, Profita G, Vella M, Cicero G Tags: Oncology Source Type: research